| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
8,304.45
|
|
Change (%)
|
-50.00 (-0.60%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
8,296.30
-
8,450.00
|
|
52-Week Range (RS)
|
6,501.60
-
10,653.05
|
|
Beta (1 Year)
|
0.42
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Astrazeneca Pharma India standalone net profit rises 5.64% in the December 2025 quarter |
| Astrazeneca Pharma India schedules board meeting |
| Volumes jump at Timken India Ltd counter |
| AstraZeneca Pharma gets CDSCO nod for import and sale of Datverzo in India |
| AstraZeneca partners with Sun Pharma for second SZC brand in India |
| Astrazeneca Pharma and Sun Pharma form second brand partnership |
| AstraZeneca Pharma slides after Q2 PAT decline 2% QoQ |
| Astrazeneca Pharma India standalone net profit rises 41.09% in the September 2025 quarter |
| Astrazeneca Pharma India to discuss results |
| Astrazeneca Pharma India Ltd - Launch Of Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5G (Lokelma) |
|
|
|
| Incoporation Year : 1979 |
| Chairman : Shilpa Divekar Nirula |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Astrazeneca Pharma India Ltd
Blk N1 12th Flr Manyata Embass,
Rachenahalli Outer Ring Road,
Bangalore,
Karnataka-560045 |
Phone:91-080-67748000
Fax:91-080-67748557 |
| E-Mail : comp.secy@astrazeneca.com |
| URL : http://www.astrazeneca.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
13-Mar-2026 |
8389.85 |
-1.02 |
| 1Month |
20-Feb-2026 |
8902.90 |
-6.72 |
| 3Month |
22-Dec-2025 |
9122.55 |
-8.97 |
| 6Month |
22-Sep-2025 |
8857.25 |
-6.24 |
| 1Year |
20-Mar-2025 |
8391.50 |
-1.04 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.86 |
583.92 |
| Bandhan Large & Mid Cap Fund |
0.77 |
114.35 |
| Bandhan Innovation Fund |
3.90 |
77.82 |
| ICICI Pru Quality Fund |
2.84 |
64.36 |
| Nippon India Pharma Fund |
0.67 |
55.37 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
26,732.20 |
0.99 |
35,921.55 |
26,000.00 |
56,805.93 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,380.90 |
0.14 |
3,515.95 |
2,220.00 |
40,333.88 |
| Pfizer Ltd |
4,771.55 |
1.03 |
5,987.65 |
3,742.90 |
21,828.76 |
| Sanofi Consumer Healthcare India Ltd |
4,256.85 |
1.07 |
5,954.00 |
3,950.50 |
9,803.79 |
| Procter & Gamble Health Ltd |
4,870.50 |
1.01 |
6,700.00 |
4,727.90 |
8,084.73 |
|
|
|
|